Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [ 18 F]-DOPA PET Imaging Study
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: While there is robust evidence of elevated dopamine synthesis capacity once a psychotic disorder has developed, little is known about whether it is altered prior to the first episode of frank illness. The authors addressed this issue by measuring dopamine synthesis capacity in individuals at ultra-high risk of psychosis and then following them to determine their clinical outcome. METHOD: This prospective study included 30 patients who met standard criteria for being at ultra-high risk of psychosis and 29 healthy volunteers. Participants were scanned using [(18)F]6-fluoro-L-dopa positron emission tomography. The ultra-high-risk patients were scanned at presentation and followed up for at least 3 years to determine their clinical outcome. Six patients had comorbid schizotypal personality disorder and were excluded from the analysis (data are provided for comparison). Of the remaining patients, nine developed a psychotic disorder (psychotic transition group) and 15 did not (nontransition group). RESULTS: There was a significant effect of group on striatal dopamine synthesis capacity. The psychotic transition group had greater dopamine synthesis capacity in the striatum (effect size=1.18) and its associative subdivision (effect size=1.24) than did the healthy comparison subjects and showed a positive correlation between dopamine synthesis capacity and symptom severity. Dopamine synthesis capacity was also significantly greater in the psychotic transition group than in the nontransition group. CONCLUSIONS: These findings provide evidence that the onset of frank psychosis is preceded by presynaptic dopaminergic dysfunction. Further research is needed to determine the specificity of elevated dopamine synthesis capacity to particular psychotic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Dopamine synthesis capacity is greater in individuals who later transition to psychosis than those who do not transition (63),”
From Aberrant Salience, Information Processing, and Dopaminergic Signaling in People at Clinical High Risk for Psychosis (2020) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,567
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
Self-citationMapping the Onset of Psychosis: The Comprehensive Assessment of At-Risk Mental States
Yung, A. R., Yung, A. R., Pan Yuen, H., Mcgorry, P. D., Phillips, L. J., Kelly, D., Dell'olio, M., Francey, S. M., Cosgrave, E. M., Killackey, E., et al. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01714.x · Cited by 2,196
Dopamine in schizophrenia: a review and reconceptualization
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1474 · Cited by 2,018
The primate basal ganglia: Parallel and integrative networks
Haber, S. N. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2003.10.003 · Cited by 1,479
Hammers, A., Allom, R., Koepp, M. J., Free, S. L., Myers, R., Lemieux, L., Mitchell, T. N., Brooks, D. J., & Duncan, J. S. (2003) · Human Brain Mapping · doi:10.1002/hbm.10123 · Cited by 1,286
Cannon, T. D., Cadenhead, K., Cornblatt, B., Woods, S. W., Addington, J., Walker, E., Seidman, L. J., Perkins, D., Tsuang, M., McGlashan, T., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.3 · Cited by 1,269
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Howes, O. D., Montgomery, A. J., Asselin, M.-C., Murray, R. M., Valli, I., Tabraham, P., Bramon-Bosch, E., Valmaggia, L., Johns, L., Broome, M., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.514 · Cited by 744
Self-citation
Research works printed but not linked: 1
- American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994 American Psychiatric Association Press Washington DC Fourth edition
Cited by
The Psychosis High-Risk State: A Comprehensive State-of-the-Art Review
Fusar-Poli, P., Borgwardt, S., Bechdolf, A., Addington, J., Riecher-Rössler, A., Schultze-Lutter, F., Keshavan, M., Wood, S., Ruhrmann, S., Seidman, L. J., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.269 · Cited by 1,483
Self-citationMcCutcheon, R. A., Reis Marques, T., & Howes, O. D. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.3360 · Cited by 1,481
Self-citationHowes, O. D., Kambeitz, J., Kim, E., Stahl, D., Slifstein, M., Abi-Dargham, A., & Kapur, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.169 · Cited by 967
Self-citationSchizophrenia: an integrated sociodevelopmental-cognitive model
Howes, O. D., & Murray, R. M. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62036-x · Cited by 864
Self-citationNeurodevelopmental model of schizophrenia: update 2012
Rapoport, J. L., Giedd, J. N., & Gogtay, N. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.23 · Cited by 790
Glutamate and dopamine in schizophrenia: An update for the 21 st century
Howes, O., McCutcheon, R., & Stone, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114563634 · Cited by 702
“Finally, the studies in the prodrome to schizophrenia provide evidence that dopamine synthesis capacity increases further with the onset of acute psychosis (Howes et al., 2011a).”
BackgroundSelf-citationDopamine and glutamate in schizophrenia: biology, symptoms and treatment
McCutcheon, R. A., Krystal, J. H., & Howes, O. D. (2020) · World Psychiatry · doi:10.1002/wps.20693 · Cited by 612
Self-citationThe Role of Genes, Stress, and Dopamine in the Development of Schizophrenia
Howes, O. D., McCutcheon, R., Owen, M. J., & Murray, R. M. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.07.014 · Cited by 601
Self-citationKaar, S. J., Natesan, S., McCutcheon, R., & Howes, O. D. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107704 · Cited by 383
Self-citationCandidate biomarkers in psychiatric disorders: state of the field
Abi‐Dargham, A., Moeller, S. J., Ali, F., DeLorenzo, C., Domschke, K., Horga, G., Jutla, A., Kotov, R., Paulus, M. P., Rubio, J. M., et al. (2023) · World Psychiatry · doi:10.1002/wps.21078 · Cited by 372
Potkin, S. G., Kane, J. M., Correll, C. U., Lindenmayer, J.-P., Agid, O., Marder, S. R., Olfson, M., & Howes, O. D. (2020) · npj Schizophrenia · doi:10.1038/s41537-019-0090-z · Cited by 359
Self-citationA review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis
Davis, J., Eyre, H., Jacka, F. N., Dodd, S., Dean, O., McEwen, S., Debnath, M., McGrath, J., Maes, M., Amminger, P., et al. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.017 · Cited by 355
Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience
Kesby, J., Eyles, D., McGrath, J., & Scott, J. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0071-9 · Cited by 352
Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
Demjaha, A., Murray, R. M., McGuire, P. K., Kapur, S., & Howes, O. D. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010144 · Cited by 325
Self-citationDemjaha, A., Egerton, A., Murray, R. M., Kapur, S., Howes, O. D., Stone, J. M., & McGuire, P. K. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.06.011 · Cited by 342
Self-citationPruessner, M., Cullen, A. E., Aas, M., & Walker, E. F. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.013 · Cited by 315
Reininghaus, U., Kempton, M. J., Valmaggia, L., Craig, T. K. J., Garety, P., Onyejiaka, A., Gayer-Anderson, C., So, S. H., Hubbard, K., Beards, S., et al. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv190 · Cited by 304
Self-citationPathway-Specific Dopamine Abnormalities in Schizophrenia
Weinstein, J. J., Chohan, M. O., Slifstein, M., Kegeles, L. S., Moore, H., & Abi-Dargham, A. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.03.2104 · Cited by 297
An integrative perspective on the role of dopamine in schizophrenia
Maia, T. V., & Frank, M. J. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.021 · Cited by 293
“Furthermore, patients at ultra-high risk of psychosis who later transition to psychosis have greater dopamine synthesis than those who do not (5) and show an increase in dopamine synthesis from the prodromal stage to psychosis (6).”
Striatal Presynaptic Dopamine in Schizophrenia, Part II: Meta-Analysis of [18F/11C]-DOPA PET Studies
Fusar-Poli, P., & Meyer-Lindenberg, A. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr180 · Cited by 262
Egerton, A., Chaddock, C. A., Winton-Brown, T. T., Bloomfield, M. A. P., Bhattacharyya, S., Allen, P., McGuire, P. K., & Howes, O. D. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.017 · Cited by 253
Self-citationKokkinou, M., Ashok, A. H., & Howes, O. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.190 · Cited by 247
Self-citationNeuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain
Cassidy, C. M., Zucca, F. A., Girgis, R. R., Baker, S. C., Weinstein, J. J., Sharp, M. E., Bellei, C., Valmadre, A., Vanegas, N., Kegeles, L. S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807983116 · Cited by 244
Connectomics: A new paradigm for understanding brain disease
Fornito, A., & Bullmore, E. T. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.02.011 · Cited by 239
Urbanicity, social adversity and psychosis
Heinz, A., Deserno, L., & Reininghaus, U. (2013) · World Psychiatry · doi:10.1002/wps.20056 · Cited by 233
Jauhar, S., Nour, M. M., Veronese, M., Rogdaki, M., Bonoldi, I., Azis, M., Turkheimer, F., McGuire, P., Young, A. H., & Howes, O. D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.2943 · Cited by 233
Self-citationDopaminergic basis of salience dysregulation in psychosis
Winton-Brown, T. T., Fusar-Poli, P., Ungless, M. A., & Howes, O. D. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2013.11.003 · Cited by 231
Self-citationBaumeister, D., Sedgwick, O., Howes, O., & Peters, E. (2017) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.10.010 · Cited by 220
“…reported no differences in DA synthesis capacity between HVHs and HCs. Increased striatal DA synthesis capacity has been a consistent finding in psychosis patients (Fusar-Poli & Meyer-Lindenberg, 2013; Howes et al., 2012) and has also been reported in at-risk individuals (Howes et al., 2011).”
BackgroundSelf-citationThe neurobiology and treatment of first-episode schizophrenia
Kahn, R. S., & Sommer, I. E. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.66 · Cited by 219
Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms
Bloomfield, M. A. P., Morgan, C. J. A., Egerton, A., Kapur, S., Curran, H. V., & Howes, O. D. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.027 · Cited by 215
Self-citationNeural and Behavioral Correlates of Aberrant Salience in Individuals at Risk for Psychosis
Roiser, J. P., Howes, O. D., Chaddock, C. A., Joyce, E. M., & McGuire, P. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs147 · Cited by 205
Self-citationMayo, D., Corey, S., Kelly, L. H., Yohannes, S., Youngquist, A. L., Stuart, B. K., Niendam, T. A., & Loewy, R. L. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00055 · Cited by 200
Howes, O. D., Williams, M., Ibrahim, K., Leung, G., Egerton, A., McGuire, P. K., & Turkheimer, F. (2013) · Brain · doi:10.1093/brain/awt264 · Cited by 198
“Nevertheless, the smallest alteration was seen in the limbic striatum, in keeping with the previous studies (Howes et al., 2009b, 2011b; Kegeles et al., 2010).”
InfluentialSelf-citationFusar-Poli, P., Byrne, M., Badger, S., Valmaggia, L. R., & McGuire, P. K. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2012.08.002 · Cited by 197
Self-citationSchizophrenia: from neurochemistry to circuits, symptoms and treatments
Howes, O. D., Bukala, B. R., & Beck, K. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-023-00904-0 · Cited by 192
Self-citationLonger-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study
Amminger, G. P., Schäfer, M. R., Schlögelhofer, M., Klier, C. M., & McGorry, P. D. (2015) · Nature Communications · doi:10.1038/ncomms8934 · Cited by 188
Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study
Jauhar, S., Veronese, M., Nour, M. M., Rogdaki, M., Hathway, P., Turkheimer, F. E., Stone, J., Egerton, A., McGuire, P., Kapur, S., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0042-4 · Cited by 183
“people at clinical high risk for psychosis [8, 9], and is specific to the later development of psychosis [8, 10], progressively increasing over the prodromal period [10], suggesting it is”
BackgroundSelf-citationAttenuated psychosis syndrome in DSM-5
Tsuang, M. T., Van Os, J., Tandon, R., Barch, D. M., Bustillo, J., Gaebel, W., Gur, R. E., Heckers, S., Malaspina, D., Owen, M. J., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.05.004 · Cited by 182
Treatment-Resistant Schizophrenia
Elkis, H., & Buckley, P. F. (2016) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2016.01.006 · Cited by 181
Childhood Onset Schizophrenia and Early Onset Schizophrenia Spectrum Disorders
Driver, D. I., Gogtay, N., & Rapoport, J. L. (2013) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2013.04.001 · Cited by 169
“It is almost certain that both dopamine and glutamate transmission are abnormal in this disorder and striatal dopamine overactivity may be critical to conversion to psychosis or psychotic symptoms generally.(56,67,68) Not only does the cause of COS elude us, several roadblocks to progress toward finding the cause rema…”
Menon, V., Palaniyappan, L. K., & Supekar, K. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.09.029 · Cited by 189
Translating the MAM model of psychosis to humans
Modinos, G., Allen, P., Grace, A. A., & McGuire, P. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2014.12.005 · Cited by 165
“This is evident in both the striatum and in the midbrain [77, 78] and a longitudinal PET study suggests that there is a progressive increase in striatal dopamine function as psychosis develops [79].”
BackgroundSelf-citationAltered Striatal Functional Connectivity in Subjects With an At-Risk Mental State for Psychosis
Dandash, O., Fornito, A., Lee, J., Keefe, R. S. E., Chee, M. W. L., Adcock, R. A., Pantelis, C., Wood, S. J., & Harrison, B. J. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt093 · Cited by 163
Early Detection and Preventive Intervention in Schizophrenia: From Fantasy to Reality
Lieberman, J. A., Small, S. A., & Girgis, R. R. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19080865 · Cited by 160
Grace, A. A., & Gomes, F. V. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx199 · Cited by 158
Bhattacharyya, S., Wilson, R., Appiah-Kusi, E., O’Neill, A., Brammer, M., Perez, J., Murray, R., Allen, P., Bossong, M. G., & McGuire, P. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.2309 · Cited by 150
Self-citationSeparate mesocortical and mesolimbic pathways encode effort and reward learning signals
Hauser, T. U., Eldar, E., & Dolan, R. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705643114 · Cited by 145
Neuroglialpharmacology: Myelination as a shared mechanism of action of psychotropic treatments
Bartzokis, G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.015 · Cited by 142
Kim, E., Howes, O. D., Veronese, M., Beck, K., Seo, S., Park, J. W., Lee, J. S., Lee, Y., & Kwon, J. S. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.258 · Cited by 146
Self-citationAttenuated Psychosis Syndrome: Ready for DSM-5.1?
Fusar-Poli, P., Carpenter, W. T., Woods, S. W., & McGlashan, T. H. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153645 · Cited by 136
Abnormalities in Hemispheric Specialization of Caudate Nucleus Connectivity in Schizophrenia
Mueller, S., Wang, D., Pan, R., Holt, D. J., & Liu, H. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.3176 · Cited by 142
Dysregulation of Midbrain Dopamine System and the Pathophysiology of Schizophrenia
Sonnenschein, S. F., Gomes, F. V., & Grace, A. A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00613 · Cited by 159
Childhood Trauma as a Cause of Psychosis: Linking Genes, Psychology, and Biology
van Winkel, R., van Nierop, M., Myin-Germeys, I., & van Os, J. (2013) · The Canadian Journal of Psychiatry · doi:10.1177/070674371305800109 · Cited by 132
Childhood-Onset Schizophrenia and Early-onset Schizophrenia Spectrum Disorders
Driver, D. I., Thomas, S., Gogtay, N., & Rapoport, J. L. (2019) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2019.08.017 · Cited by 176
Allen, P., Chaddock, C. A., Egerton, A., Howes, O. D., Bonoldi, I., Zelaya, F., Bhattacharyya, S., Murray, R., & McGuire, P. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15040485 · Cited by 127
Self-citationGomes, F. V., Rincón-Cortés, M., & Grace, A. A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.05.030 · Cited by 126
Mishara, A. L., & Fusar-Poli, P. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs155 · Cited by 118
Bernard, J. A., Russell, C. E., Newberry, R. E., Goen, J. R. M., & Mittal, V. A. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.01.034 · Cited by 118
Howes, O. D., Hird, E. J., Adams, R. A., Corlett, P. R., & McGuire, P. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.03.012 · Cited by 110
Self-citationDopamine, Prediction Error and Beyond
Diederen, K. M. J., & Fletcher, P. C. (2021) · The Neuroscientist · doi:10.1177/1073858420907591 · Cited by 106
Du, Y., & Grace, A. A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.101 · Cited by 105
Carney, R., Cotter, J., Bradshaw, T., Firth, J., & Yung, A. R. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.010 · Cited by 104
An integrative framework for perceptual disturbances in psychosis
Horga, G., & Abi-Dargham, A. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0234-1 · Cited by 103
Adversity in childhood linked to elevated striatal dopamine function in adulthood
Egerton, A., Valmaggia, L. R., Howes, O. D., Day, F., Chaddock, C. A., Allen, P., Winton-Brown, T. T., Bloomfield, M. A. P., Bhattacharyya, S., Chilcott, J., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.06.005 · Cited by 103
Self-citationPotential Roles of Redox Dysregulation in the Development of Schizophrenia
Perkins, D. O., Jeffries, C. D., & Do, K. Q. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.03.016 · Cited by 103
Kokkinou, M., Irvine, E. E., Bonsall, D. R., Natesan, S., Wells, L. A., Smith, M., Glegola, J. A., Paul, E. J., Tossell, K., Veronese, M., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0740-6 · Cited by 116
Self-citationLataster, T., Valmaggia, L., Lardinois, M., van Os, J., & Myin-Germeys, I. (2013) · Psychological Medicine · doi:10.1017/s0033291712002279 · Cited by 98
Self-citationXu, H., & Yang, F. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02233-0 · Cited by 135
Schultze‐Lutter, F., Debbané, M., Theodoridou, A., Wood, S. J., Raballo, A., Michel, C., Schmidt, S. J., Kindler, J., Ruhrmann, S., & Uhlhaas, P. J. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00009 · Cited by 109
Structural and functional imaging markers for susceptibility to psychosis
Andreou, C., & Borgwardt, S. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0679-7 · Cited by 106
Striatal glutamate and the conversion to psychosis: a prospective 1H-MRS imaging study
de la Fuente-Sandoval, C., León-Ortiz, P., Azcárraga, M., Favila, R., Stephano, S., & Graff-Guerrero, A. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000314 · Cited by 88
Violence Among People with Schizophrenia: Phenotypes and Neurobiology
Hodgins, S., Piatosa, M. J., & Schiffer, B. (2013) · Current topics in behavioral neurosciences · doi:10.1007/7854_2013_259 · Cited by 100
Howes, O. D., Shotbolt, P., Bloomfield, M., Daalman, K., Demjaha, A., Diederen, K. M. J., Ibrahim, K., Kim, E., McGuire, P., Kahn, R. S., et al. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr195 · Cited by 91
Self-citationNatural Language Processing markers in first episode psychosis and people at clinical high-risk
Morgan, S. E., Diederen, K. M. J., Vértes, P. E., Ip, S., Wang, B., Thompson, B., Demjaha, A., Micheli, A. D., Oliver, D., Liakata, M., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01722-y · Cited by 109
Self-citationEgerton, A., Stone, J. M., Chaddock, C. A., Barker, G. J., Bonoldi, I., Howard, R. M., Merritt, K., Allen, P., Howes, O. D., Murray, R. M., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.143 · Cited by 85
Self-citationThakkar, K. N., Rösler, L., Wijnen, J. P., Boer, V. O., Klomp, D. W. J., Cahn, W., Kahn, R. S., & Neggers, S. F. W. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.04.007 · Cited by 96
Neural signals encoding shifts in beliefs
Schwartenbeck, P., FitzGerald, T. H. B., & Dolan, R. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2015.10.067 · Cited by 82
Bossong, M. G., Antoniades, M., Azis, M., Samson, C., Quinn, B., Bonoldi, I., Modinos, G., Perez, J., Howes, O. D., Stone, J. M., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3252 · Cited by 81
Self-citationBartzokis, G., Lu, P. H., Raven, E. P., Amar, C. P., Detore, N. R., Couvrette, A. J., Mintz, J., Ventura, J., Casaus, L. R., Luo, J. S., et al. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.06.036 · Cited by 81
Dopamine, fronto-striato-thalamic circuits and risk for psychosis
Dandash, O., Pantelis, C., & Fornito, A. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.08.020 · Cited by 84
Gogos, A., Sbisa, A. M., Witkamp, D., & van den Buuse, M. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14671 · Cited by 88
Shao, J., Meng, C., Tahmasian, M., Brandl, F., Yang, Q., Luo, G., Luo, C., Yao, D., Gao, L., Riedl, V., et al. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-018-9838-8 · Cited by 81
Opportunities and Challenges for Psychiatry in the Connectomic Era
Fornito, A., Bullmore, E. T., & Zalesky, A. (2017) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2016.08.003 · Cited by 74
Luhrmann, T. M., Alderson-Day, B., Bell, V., Bless, J. J., Corlett, P., Hugdahl, K., Jones, N., Larøi, F., Moseley, P., Padmavati, R., et al. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby110 · Cited by 73
Salavati, B., Rajji, T. K., Price, R., Sun, Y., Graff‐Guerrero, A., & Daskalakis, Z. J. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu132 · Cited by 77
Avram, M., Brandl, F., Cabello, J., Leucht, C., Scherr, M., Mustafa, M., Leucht, S., Ziegler, S., & Sorg, C. (2019) · Brain · doi:10.1093/brain/awz093 · Cited by 70
Reduced presynaptic dopamine activity in adolescent dorsal striatum
Matthews, M., Bondi, C., Torres, G., & Moghaddam, B. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.32 · Cited by 67
The Dopamine Dysfunction in Schizophrenia Revisited: New Insights into Topography and Course
Kuepper, R., Skinbjerg, M., & Abi‐Dargham, A. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_1 · Cited by 76
Allott, K., Schäfer, M. R., Thompson, A. D., Nelson, B., Bendall, S., Bartholomeusz, C. F., Yuen, H. P., McGorry, P. D., Schlögelhofer, M., Bechdolf, A., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.01.037 · Cited by 71
Sarpal, D. K., Robinson, D. G., Fales, C. L., Lencz, T., Árgyelán, M., Karlsgodt, K. H., Gallego, J. A., John, M., Kane, J. M., Szeszko, P. R., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.55 · Cited by 67
D. Howes, O., Fusar-Poli, P., Bloomfield, M., Selvaraj, S., & McGuire, P. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799316217 · Cited by 62
Self-citationWilson, R., Bossong, M. G., Appiah-Kusi, E., Petros, N., Brammer, M., Perez, J., Allen, P., McGuire, P., & Bhattacharyya, S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0534-2 · Cited by 63
Self-citationGevonden, M., Booij, J., van den Brink, W., Heijtel, D., van Os, J., & Selten, J.-P. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1325 · Cited by 62
Schiffer, B., Leygraf, N., Müller, B. W., Scherbaum, N., Forsting, M., Wiltfang, J., Gizewski, E. R., & Hodgins, S. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs115 · Cited by 66
Wotruba, D., Heekeren, K., Michels, L., Buechler, R., Simon, J. J., Theodoridou, A., Kollias, S., Rössler, W., & Kaiser, S. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00382 · Cited by 61
Regulation of dopaminergic function: an [18F]-DOPA PET apomorphine challenge study in humans.
Jauhar, S., Veronese, M., Rogdaki, M., Bloomfield, M., Natesan, S., Turkheimer, F., Kapur, S., & Howes, O. D. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.270 · Cited by 61
Self-citationGlycine treatment of the risk syndrome for psychosis: Report of two pilot studies
Woods, S. W., Walsh, B. C., Hawkins, K. A., Miller, T. J., Saksa, J. R., D'Souza, D. C., Pearlson, G. D., Javitt, D. C., McGlashan, T. H., & Krystal, J. H. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.09.008 · Cited by 60
Allen, P., Chaddock, C. A., Egerton, A., Howes, O. D., Barker, G. J., Bonoldi, I., Fusar‐Poli, P., Murray, R. M., & McGuire, P. K. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu115 · Cited by 66
Self-citationIncreased Striatal and Reduced Prefrontal Cerebral Blood Flow in Clinical High Risk for Psychosis
Kindler, J., Schultze‐Lutter, F., Hauf, M., Dierks, T., Federspiel, A., Walther, S., SCHIMMELMANN, B. G., & Hubl, D. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx070 · Cited by 65
Veronese, M., Santangelo, B., Jauhar, S., D’Ambrosio, E., Demjaha, A., Salimbeni, H., Jin, H., McCrone, P., Turkheimer, F., & Howes, O. D. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00866-7 · Cited by 58
Self-citation
Metadata
- Authors
- Howes, O. D., Bose, S. K., Turkheimer, F., Valli, I., Egerton, A., Valmaggia, L. R., Murray, R. M., & McGuire, P.
- Affiliations
- King's College London (GB)
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2011-12
- Volume
- 168
- Issue
- 12
- Pages
- 1311-1317
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- PMC
- PMC3682447
- OpenAlex
- W2143870537
- Cited by
- 343
- References
- 40
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 16 · 2023: 17 · 2022: 24 · 2021: 17 · 2020: 29 · 2019: 30 · 2018: 20 · 2017: 22 · 2016: 37 · 2015: 21 · 2014: 27 · 2013: 31 · 2012: 26
- FWCI
- 18.93
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- South London and Maudsley NHS Foundation Trust
- Medical Research Council
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- dopamine synthesis capacity, clinical high risk for psychosis, first-episode psychosis, striatum, 18F-DOPA PET, symptom severity, schizophrenia, schizotypal personality disorder
- MeSH terms
- Adult, Brain, Corpus Striatum, Dopamine, Female, Humans, Male, Prospective Studies, Psychotic Disorders, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.